Challenges for paediatric oncology in Africa

The Lancet Oncology

Volumn 14, Issue 4, 2013, Pages 279-281

  Harif, Mhamed ^a   Traoré, Fousseyni ^b   Hessissen, Laila ^c   Moreira, Claude ^d   Atteby, Jean Jacques ^e  

^a CENTRE HOSPITALIER UNIVERSITAIRE MOHAMMED VI   (Morocco)

^b HÔPITAL GABRIEL TOURÉ   (Mali)

^c IBN SINA HOSPITAL   (Morocco)

^d Centre Hospitalier Universitaire Aristide Le Dantec de Dakar   (Senegal)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AFRICA; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD HEALTH CARE; CHILDHOOD CANCER; DRUG FATALITY; DRUG MEGADOSE; EVENT FREE SURVIVAL; HEALTH CARE AVAILABILITY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH PROGRAM; HODGKIN DISEASE; HUMAN; LETTER; METABOLIC DISORDER; NEPHROBLASTOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; RETINOBLASTOMA; SURVIVAL RATE; SURVIVAL TIME; SUSTAINABLE DEVELOPMENT;

AFRICA; CHILD; CHILD, PRESCHOOL; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS;

EID: 84875779689     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70569-7     Document Type: Letter

References (12)

1. Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 2005, 23:3742-3751.
2. Howard SC, Metzger ML, Wilimas JA, et al. Childhood cancer epidemiology in low-income countries. Cancer 2008, 112:461-472.
3. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008, 9:721-729.
4. World population prospects, the 2010 revision. UN Department of Economic and Social Affairs, Population Division (Population Estimates and Projections Section) (accessed Dec 2, 2012). http://esa.un.org/unpd/wpp/Sorting-Tables/tab-sorting_ageing.htm.
5. Lemerle J, Barsaoui S, Harif M, et al. Le traitement des cancers de l'enfant en Afrique-travaux du Groupe Franco-Africain d'Oncologie Pédiatrique. Med Trop (Mars) 2007, 67:497-504.
6. Harif M, Barsaoui S, Benchekroun S, et al. Treatment of B-cell lymphoma with LMB modified protocols in Africa-report of the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer 2008, 50:1138-1142.
7. Madani A, Benhmidoune L, Zafad S, Harif M, Quessar A, Benchekroun S Traitement du lymphome de Burkitt de l'enfant par le protocole LMB89 à Casablanca. Bull Cancer 2005, 92:193-198.
8. Hesseling P, Broadhead R, Wright C, et al. Intravenous high frequency cyclophosphamide plus intrathecal methotrexate for endemic Burkitt lymphoma-interim results. International Society of Paediatric Oncology, SIOP XXXVI Congress Meeting: abstracts. Pediatr Blood Cancer 2004, 43:401.
9. Traoré F, Coze C, Atteby J-J, et al. Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer 2011, 56:70-76.
10. Tournade MF, Com-Nougué C, de Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001, 19:488-500. for the International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee.
11. Moreira C, Nachef MN, Ziamati S, et al. Treatment of nephroblastoma in Africa: results of the first French African Pediatric Oncology Group (GFAOP) study. Pediatr Blood Cancer 2012, 58:37-42.
12. Madani A, Zafad S, Harif M, et al. Treatment of Wilms tumor according to SIOP 9 protocol in Casablanca, Morocco. Pediatr Blood Cancer 2006, 46:472-475.